These findings indicate that TA-MUC1, particularly when aberrantly expressed in cancer, acts as a metabolic master regulator and exerts multiple effects on cholesterol and lipid metabolism, and thereby has the potential to act as an important pathogenic contributor to atherosclerosis. Here, MUC1 is linked to atherosclerosis.